Viewing Study NCT02107950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:53 PM
Ignite Modification Date: 2026-02-25 @ 6:59 PM
Study NCT ID: NCT02107950
Status: COMPLETED
Last Update Posted: 2018-08-15
First Post: 2014-04-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma
Sponsor: SOTIO a.s.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Neoplasms View
None Ovarian Cancer (OvCa) View
None Ovarian Epithelial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian View
None Platinum Sensitive View
None Epithelial View